Valuation Hansoh Pharmaceutical Group Company Limited

Equities

Market Closed - Hong Kong S.E. Other stock markets 09:09:12 05/06/2026 BST			5-day change	1st Jan Change
29.32 ^HKD	-1.61%		-6.74%	-18.74%

06-04	Hansoh Pharmaceutical's Weight-loss Injection Enters China Review	MT
05-28	Higher Crude, Persian Gulf Outlooks Lowers Asian Stock Markets	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	91,671	77,721	84,742	96,362	196,284	153,693	-	-
Change	-	-15.22%	9.03%	13.71%	103.7%	-21.7%	-	-
Enterprise Value (EV) ¹	76,969	60,106	64,620	73,033	164,735	118,974	113,666	109,763
Change	-	-21.91%	7.51%	13.02%	125.56%	-27.78%	-4.46%	-3.43%
P/E ratio	35.2x	29.8x	26x	22.2x	34.9x	25.7x	23.4x	20.5x
PBR	4.58x	3.43x	3.29x	3.36x	5.55x	3.9x	3.42x	3.05x
PEG	-	-	1x	0.7x	1.3x	4.34x	2.3x	1.5x
Capitalization / Revenue	9.23x	8.28x	8.39x	7.86x	13.1x	9.07x	8.27x	7.23x
EV / Revenue	7.75x	6.41x	6.4x	5.96x	11x	7.02x	6.11x	5.17x
EV / EBITDA	24.2x	19.9x	20.8x	16.8x	28.3x	18.2x	15.8x	13.2x
EV / EBIT	26.6x	22.5x	23.6x	18.5x	30.3x	19.5x	16.9x	14.2x
EV / FCF	36.6x	24.3x	23.5x	20.5x	-	21.3x	19.1x	15.4x
FCF Yield	2.73%	4.11%	4.26%	4.87%	-	4.7%	5.23%	6.51%
Dividend per Share ²	0.0732	0.1	0.2129	0.3363	0.4316	0.3557	0.3834	0.4239
Rate of return	0.47%	0.76%	1.49%	2.07%	1.33%	1.4%	1.51%	1.67%
EPS ²	0.44	0.44	0.55	0.73	0.93	0.9851	1.085	1.234
Distribution rate	16.6%	22.7%	38.7%	46.1%	46.4%	36.1%	35.3%	34.4%
Net sales ¹	9,935	9,382	10,104	12,261	15,028	16,948	18,594	21,250
EBITDA ¹	3,175	3,019	3,101	4,347	5,830	6,533	7,210	8,307
EBIT ¹	2,897	2,674	2,735	3,945	5,437	6,100	6,708	7,723
Net income ¹	2,713	2,584	3,278	4,372	5,555	5,900	6,517	7,432
Net Debt ¹	-14,702	-17,615	-20,122	-23,328	-31,549	-34,718	-40,027	-43,929
Reference price ²	15.48	13.13	14.31	16.24	32.42	25.35	25.35	25.35
Nbr of stocks (in thousands)	5,922,350	5,920,764	5,923,735	5,934,335	6,053,955	6,062,955	-	-
Announcement Date	29/03/22	27/03/23	26/03/24	21/03/25	29/03/26	-	-	-

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED	25.73x	7.02x	18.21x	1.4%	22.69B
ELI LILLY AND COMPANY	33.11x	12.04x	24.78x	0.6%	1,009B
JOHNSON & JOHNSON	24.88x	5.74x	15.6x	2.29%	560B
ABBVIE INC.	27.82x	6.77x	13.84x	3.02%	401B
ROCHE HOLDING AG	17.55x	4.34x	10.65x	3.07%	328B
ASTRAZENECA PLC	23.42x	4.85x	13.81x	1.8%	288B
NOVARTIS AG	20.62x	5.32x	12.95x	3.06%	272B
NOVO NORDISK A/S	12.56x	4.71x	9.62x	4%	194B
AMGEN INC.	22.73x	6.08x	10.62x	2.89%	189B
GILEAD SCIENCES, INC.	-46.22x	5.58x	31.48x	2.51%	160B
Average	16.22x	6.24x	16.16x	2.46%	342.43B
Weighted average by Cap.	22.34x	7.43x	17.41x	2.11%